 Scopus Biopharma Inc NASDAQ: SCPS shares, which debuted on the Nasdaq Wednesday, are ripping higher. What Happened: New York-based Scopus, a biopharma company developing therapeutics for serious diseases with significant unmet needs, offered 500,000 shares through a Regulation A Tier 2 offering. 